Gentuximab

DRUG2 trials

Sponsors

Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions

Advanced Gastric or Gastroesophageal Junction CancerMetastatic Non-Small Cell Lung Cancer

Phase 1

A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction Cancer

CompletedNCT04053205

Changchun GeneScience Pharmaceutical Co., Ltd.Advanced Gastric or Gastroesophageal Junction Cancer

Start: 2019-11-05End: 2020-09-20Updated: 2026-05-22

A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

Changchun GeneScience Pharmaceutical Co., Ltd.Metastatic Non-Small Cell Lung Cancer

Start: 2021-04-02End: 2024-01-30Target: 42Updated: 2022-02-04